Ligand recognition by murine anti-DNA autoantibodies. II. Genetic analysis and pathogenicity

The Journal of Clinical Investigation
P C SwansonGary D Glick

Abstract

Although anti-DNA autoantibodies are an important hallmark of lupus, the relationships among anti-DNA structure, reactivity, and pathogenicity have not been fully elucidated. To further investigate these relationships, we compare the variable genes and primary structure of eight anti-DNA mAbs previously obtained from an MRL/MpJ-lpr/lpr mouse along with the ability of three representative mAbs to induce nephritis in nonautoimmune mice using established adoptive transfer protocols. One monospecific anti-single-stranded (ss) DNA (11F8) induces severe diffuse proliferative glomerulonephritis in nonautoimmune mice whereas another anti-ssDNA with apparently similar in vitro binding properties (9F11) and an anti-double-stranded DNA (4B2) are essentially benign. These results establish a murine model of anti-DNA-induced glomerular injury resembling the severe nephritis seen in lupus patients and provide direct evidence that anti-ssDNA can be more pathogenic than anti-double-stranded DNA. In vitro binding experiments using both protein-DNA complexes and naive kidney tissue indicate that glomerular localization of 11F8 may occur by recognition of a planted antigen in vivo. Binding to this antigen is DNase sensitive which suggests that DN...Continue Reading

References

Mar 1, 1978·The Journal of Experimental Medicine·W Emlen, M Mannik
Aug 1, 1992·Immunological Reviews·T N MarionR J Hill
Dec 1, 1992·Kidney International·R M TermaatJ H Berden
Jun 1, 1992·Kidney International·D V VlahakosM P Madaio
Jan 1, 1992·Annual Review of Immunology·B DiamondM D Scharff
Jan 1, 1992·Kidney International·R LemoineS Izui
Jun 1, 1991·The Journal of Experimental Medicine·H GuI Förster
Jan 1, 1990·The Journal of Experimental Medicine·M ShlomchikM Weigert
Jan 1, 1990·The Journal of Experimental Medicine·S Litwin, M Shlomchik
Jan 1, 1986·Springer Seminars in Immunopathology·A N TheofilopoulosF J Dixon
Feb 1, 1987·The Journal of Experimental Medicine·P MiglioriniR S Schwartz
Feb 1, 1988·Kidney International·G J Fournié
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M J ShlomchikM G Weigert
Aug 2, 1987·Nature·M J ShlomchikM G Weigert
Mar 6, 1986·The New England Journal of Medicine·H A AustinJ L Decker
Oct 1, 1967·The Journal of Experimental Medicine·D KofflerH G Kunkel
Mar 1, 1968·The Journal of Experimental Medicine·P H Lambert, F J Dixon
May 1, 1971·Annals of the Rheumatic Diseases·G R HughesC L Christian
Jul 1, 1971·The Journal of Experimental Medicine·D KofflerH G Kunkel
Jan 1, 1982·The Journal of Experimental Medicine·Y Kurosawa, S Tonegawa
Sep 1, 1995·Kidney International·M R EhrensteinD A Isenberg
Jul 1, 1995·European Journal of Immunology·M HerrmannJ R Kalden
Jan 1, 1994·Annual Review of Immunology·M Z Radic, M Weigert
Sep 1, 1994·The Journal of Experimental Medicine·J B KatzB Diamond

❮ Previous
Next ❯

Citations

Jun 1, 1996·Arthritis and Rheumatism·J B Lefkowith, G S Gilkeson
Mar 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M TeodorescuR L Rubin
Mar 24, 2005·Journal of Molecular Biology·Jonathan P SchuermannJohn J Tanner
Sep 11, 2002·Molecular Immunology·Leian ChenChandra Mohan
Oct 8, 1999·Pharmacology & Therapeutics·N B Blatt, G D Glick
Feb 6, 2004·The Journal of Experimental Medicine·Zhiyan LiangChandra Mohan
Apr 2, 1998·Hybridoma·N B BlattG D Glick
Aug 26, 1998·The Journal of Clinical Investigation·T DörnerP E Lipsky
Apr 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mitsugu AkagawaKoji Uchida
Apr 7, 1997·The Journal of Experimental Medicine·L SpatzB Diamond
May 22, 2007·Journal of Molecular Biology·Santiago SanguinetiGonzalo de Prat-Gay
Nov 24, 2004·Protein Science : a Publication of the Protein Society·Hulin JinOscar R Burrone
Sep 25, 2014·Dose-response : a Publication of International Hormesis Society·Noriko Shimura, Shuji Kojima
Nov 22, 2007·Journal of Molecular Biology·Zhonghui OuJohn J Tanner
Dec 6, 2001·Journal of Molecular Biology·J J TannerS L Deutscher
Jan 1, 1997·Lupus·J K Kalsi, B Sutton
Mar 13, 2003·Arthritis and Rheumatism·Jeffrey J BednarskiGary D Glick
Jan 26, 2007·Biopolymers·Melissa J Bobeck, Gary D Glick
Jan 26, 2007·Biopolymers·Melissa J BobeckGary D Glick
Sep 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhiyan LiangChandra Mohan
Jul 20, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·H A GussinM Teodorescu
Apr 12, 2003·Biochemistry·Jennifer A BeckinghamGary D Glick
Jan 8, 2003·Biochemistry·Joanne Cleary, Gary D Glick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.